Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Yosef E. Maruvka et al.|Nature|2018Cited by 943
Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Rohith T. Nagari et al.|Nature Cancer|2020Cited by 880
Phosphorylation of the PTEN Tail Regulates Protein Stability and FunctionFrancisca Vázquez, William R. Sellers, Shivapriya Ramaswamy et al.|Molecular and Cellular Biology|2000Cited by 779
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J. Aguirre, William C. Hahn, Robin M. Meyers et al.|Cancer Discovery|2016Cited by 632
Cas9 activates the p53 pathway and selects for p53-inactivating mutationsOana M. Enache, Uri Ben‐David, Verónica Rendo et al.|Nature Genetics|2020Cited by 285